Bavelloni, Alberto, Manuela Piazzi, Giulia Ramazzotti, Roberta Fiume, William Blalock, and Irene Faenza. “PI3Kα-Selective Inhibitor Alpelisib (BYL719), May Be Effective As Anticancer Agents in Rhabdomyosarcoma”. Italian Journal of Anatomy and Embryology 122, no. 1 (October 6, 2017): 21. Accessed May 1, 2024. https://oajournals.fupress.net/index.php/ijae/article/view/1730.